U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06823791) titled 'Furazolidone Quadruple Regimen Eradicate H. Pylori Infection' on Sept. 04, 2023.
Brief Summary: Research protocol:
Experimental group:
First line solution (furazolidone regimen): esomeprazole magnesium 20 mg +colloidal bismuth pectin 200mg+ amoxicillin 1000 mg + furazolidone 100 mg, twice daily, for 14 days.
Patients who is still positive for H. pylori infection after the first line solution select the second line solution (high-dose dual regimen): esomeprazole magnesium 20 mg and amoxicillin 750 mg, 4 times daily, for 14 days.
Control group:
First line solution (clarithromycin regimen): esomeprazole magnesium 20 mg +colloidal ...